Lamotrigine (Lamictal) is an anticonvulsant and mood stabilizer approved for epilepsy (partial-onset and generalized tonic-clonic seizures) and bipolar I disorder — particularly effective at preventing depressive episodes. It stabilizes neuronal membranes by blocking voltage-gated sodium channels, reducing pathological excitability. Common side effects include dizziness, headache, and diplopia. A serious warning: lamotrigine requires a very slow dose titration schedule because faster escalation dramatically raises the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis — potentially life-threatening skin reactions.
Lamotrigine
Lamotrigine is an anticonvulsant medication that has become an important mood stabilizer for bipolar disorder, particularly for preventing depressive episodes. It is notable for its lack of weight gain and sedation relative to many other mood stabilizers, but requires a very slow titration schedule due to the risk of serious skin reactions.
Uses & FDA Indications
Lamotrigine is approved both as an anticonvulsant and as a mood stabilizer. Its bipolar indication is specifically for maintenance (prevention) rather than acute treatment of mania.
FDA-Approved Uses
- Epilepsy (partial-onset seizures) — adjunctive therapy in adults and children aged 2 and older
- Epilepsy (primary generalized tonic-clonic seizures) — adjunctive therapy in adults and children aged 2 and older
- Lennox-Gastaut syndrome — adjunctive therapy in patients aged 2 and older
- Bipolar I disorder, maintenance — delay in occurrence of mood episodes in adults already treated for acute mood episodes
Off-Label Uses
- Bipolar II disorder
- Bipolar depression (acute)
- Borderline personality disorder
- Neuropathic pain
- PTSD adjunct
How It Works
Lamotrigine's primary mechanism is blockade of voltage-gated sodium channels. By stabilizing neuronal membranes in their inactivated state, it reduces the repetitive firing of neurons that underlies both seizures and, presumably, certain aspects of mood cycling. It also inhibits presynaptic calcium channels, reducing the release of excitatory neurotransmitters, particularly glutamate.
The reduction in pathological glutamate release is thought to be especially relevant to its mood-stabilizing and antidepressant properties. Unlike lithium and valproate — which are more effective against mania — lamotrigine is more protective against bipolar depression, a characteristic attributed to its modulation of glutamatergic neurotransmission in limbic circuits.
Lamotrigine is metabolized primarily by glucuronidation (UGT enzymes) in the liver. This makes it susceptible to drug interactions with valproate (which dramatically increases lamotrigine levels) and enzyme-inducing anticonvulsants (which dramatically decrease levels).
Side Effects
Common
- Headache and dizziness
- Nausea and vomiting
- Diplopia (double vision) and blurred vision
- Ataxia (coordination problems) — especially at higher levels
- Insomnia or somnolence
- Benign rash (occurs in ~10% of patients; usually mild but must be distinguished from serious reactions)
- Tremor
Serious
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) — rare but life-threatening skin reactions; risk is highest with rapid titration or with concurrent valproate
- Drug reaction with eosinophilia and systemic symptoms (DRESS) — systemic hypersensitivity with organ involvement
- Aseptic meningitis — rare; presents with headache, fever, stiff neck, rash
- Hemophagocytic lymphohistiocytosis (HLH) — rare, potentially fatal immune dysregulation
- Suicidal ideation — class-wide FDA warning for anticonvulsants
BLACK BOX WARNING: Serious skin reactions including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have occurred with lamotrigine. Risk is highest when started at too high a dose or increased too quickly, and when combined with valproate. Any new rash during therapy should be evaluated by a clinician immediately — do not dismiss it as benign without medical assessment.
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Valproate / valproic acid (Depakote) | Inhibits lamotrigine glucuronidation; approximately doubles lamotrigine plasma levels; dramatically increases SJS risk if titration is not slowed | Critical — slower titration schedule required; lower target doses used |
| Enzyme-inducing antiepileptics (carbamazepine, phenytoin, phenobarbital, primidone) | Induce UGT enzymes, reducing lamotrigine levels by approximately 50% | High — higher lamotrigine exposures required when used with inducers |
| Oral contraceptives (estrogen-containing) | Induce lamotrigine glucuronidation; reduce lamotrigine levels by ~50%; levels may surge during pill-free weeks | High — significant mood instability or seizure breakthrough possible; hormone-free days require monitoring |
| Rifampin | Potent enzyme inducer; substantially reduces lamotrigine levels | High — dose adjustment needed during and after rifampin course |
| Lithium | Pharmacokinetic interaction minimal; additive CNS effects possible | Low–Moderate — commonly combined; generally well tolerated |
| Sertraline | Mild increase in lamotrigine levels reported; mechanism not fully established | Low — monitor for lamotrigine side effects when adding sertraline |
| Alcohol / CNS depressants | Additive CNS depression; impaired coordination and alertness | Moderate — advise caution and avoid excessive alcohol |
Warnings & Contraindications
Lamotrigine is contraindicated in patients with known hypersensitivity to the drug or any of its components. Prior SJS/TEN from lamotrigine is an absolute contraindication to restarting it.
Key Precautions
- Rash protocol: Any new rash must be evaluated promptly — it should be considered potentially serious until proven otherwise; lamotrigine may need to be stopped
- Slow titration: The titration schedule is not optional; it substantially reduces the risk of serious skin reactions
- Do not restart after stopping: Patients who stop lamotrigine for more than a few days should restart at the beginning of the titration schedule, not at the previous dose
- Pregnancy effects: Estrogen changes during pregnancy alter lamotrigine clearance; levels may fall significantly, requiring monitoring and possible adjustments
- Suicidality: All anticonvulsants carry an FDA warning regarding increased risk of suicidal thoughts; monitor patients closely
Frequently Asked Questions
Why does lamotrigine need to be increased so slowly?
The risk of Stevens-Johnson syndrome — a potentially life-threatening skin reaction — is strongly associated with how fast lamotrigine is initiated or escalated. A slow titration schedule over several weeks allows the body to develop tolerance without triggering an immune-mediated reaction. When combined with valproate, which increases lamotrigine blood levels, the titration schedule is even slower. Skipping or compressing the schedule significantly increases the risk of serious rash.
What should I do if I develop a rash on lamotrigine?
Contact your prescriber immediately. While many rashes on lamotrigine are benign, some can progress to Stevens-Johnson syndrome, which is a medical emergency. Your doctor will evaluate the rash characteristics to determine whether lamotrigine must be stopped. Rashes that appear during the first 2–8 weeks of therapy, are spreading, involve mucous membranes, or are accompanied by fever warrant urgent evaluation.
How does lamotrigine compare to lithium for bipolar disorder?
Lithium and lamotrigine are complementary rather than identical. Lithium is more effective at preventing manic episodes, whereas lamotrigine is more protective against depressive episodes — making it particularly valuable for bipolar II disorder or patients with predominantly depressive cycling. Lamotrigine does not cause weight gain, hypothyroidism, or the kidney concerns associated with lithium, and does not require blood level monitoring. However, it requires slow titration and carries the rash risk.
Does lamotrigine interact with birth control?
Yes — this is a clinically important interaction. Estrogen-containing oral contraceptives accelerate lamotrigine metabolism, sometimes cutting blood levels in half. This can cause breakthrough seizures or mood episodes. Conversely, during the pill-free week, levels may spike, causing side effects. Patients on lamotrigine who use hormonal contraceptives should discuss this with both their prescriber and gynecologist, and may need to consider non-estrogen-based contraception.
Need to identify a pill? Use the PillID visual search tool.
Identify a Pill →